EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C6H6Br2N2 |
| Net Charge | 0 |
| Average Mass | 265.936 |
| Monoisotopic Mass | 263.88977 |
| SMILES | N#CCCC(Br)(C#N)CBr |
| InChI | InChI=1S/C6H6Br2N2/c7-4-6(8,5-10)2-1-3-9/h1-2,4H2 |
| InChIKey | DHVLDKHFGIVEIP-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | allergen A chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy. sensitiser A chemical compound that causes a substantial proportion of exposed people or animals to develop an allergic reaction in normal tissue after repeated exposure to the compound. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 2-bromo-2-(bromomethyl)pentanedinitrile (CHEBI:62823) has role allergen (CHEBI:50904) |
| 2-bromo-2-(bromomethyl)pentanedinitrile (CHEBI:62823) has role sensitiser (CHEBI:139492) |
| 2-bromo-2-(bromomethyl)pentanedinitrile (CHEBI:62823) is a aliphatic nitrile (CHEBI:80291) |
| 2-bromo-2-(bromomethyl)pentanedinitrile (CHEBI:62823) is a organobromine compound (CHEBI:37141) |
| Incoming Relation(s) |
| Euxyl K 400 (CHEBI:144318) has part 2-bromo-2-(bromomethyl)pentanedinitrile (CHEBI:62823) |
| IUPAC Name |
|---|
| 2-bromo-2-(bromomethyl)pentanedinitrile |
| Synonyms | Source |
|---|---|
| 2-Bromo-2-bromomethylglutaronitrile | ChemIDplus |
| 1-Bromo-1-(bromomethyl)-1,3-propanedicarbonitrile | ChemIDplus |
| Methyldibromoglutaronitrile | ChemIDplus |
| 1,2-Dibromo-2,4-dicyanobutane | ChemIDplus |
| 2-Bromo-2-(bromomethyl)glutaronitrile | ChemIDplus |
| Bromothalonil | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| EP1188377 | Patent |
| CN101617668 | Patent |
| CN101642109 | Patent |
| CN101595876 | Patent |
| CN101595879 | Patent |
| Methyldibromo_glutaronitrile | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:1930600 | Reaxys |
| CAS:35691-65-7 | ChemIDplus |
| Citations |
|---|